Case Study: BioPharma AI Platform | Silicon Development Skip to main content

Case Study · BioPharma · AI Drug Discovery

BioPharma AI Drug Discovery Platform

10 engineers. 400+ tickets. Research tooling to production SaaS.

A biotech company needed to turn its RNA splicing research into a commercial platform that pharmaceutical clients could use for drug discovery. The internal team had the science and the ML pipeline. They did not have the engineering capacity to build the production application around it. Silicon Development embedded a 10-person team to build the platform from scratch.

Engagement

12+ months

Full platform build

Engineers

10

Cross-functional team

Tickets delivered

400+

Features, bugs, infra, UX

Relationship

8+ years

Still in contact with founders

What the team needed

The client had ML algorithms that analyzed RNA splicing across a large proprietary event database. The research worked. But the tooling was built for scientists, not for pharma partners who needed to run experiments, manage datasets, and review results inside a real product.

They needed a multi-tenant SaaS platform on Azure. The platform had to handle 100+ TB-class genomic datasets, render scientific visualizations in-browser, support branded environments for multiple pharma accounts, and enforce role-based access controls across organizations.

The engineers had to work directly with the life sciences team. The domain is specialized enough that you cannot hand off a spec and expect useful output. The team needed to understand splicing events, case-control experiment design, and how bioinformaticians actually work with data.

Stack

Backend

Ruby on Rails

Frontend

Bootstrap, AG-Grid, Plotly.js

Infrastructure

Microsoft Azure, Docker

Integrations

Genome browser context, scientific data sources, error tracking

What Silicon Development built

The platform that shipped as the client's commercial product.

Experiment engine

Scientists configure and run RNA splicing analysis jobs against the client's ML pipeline, review results inside the product, and iterate on experiments without falling back to research-only tooling.

Results data grid

A high-volume results workspace built for filtering, sorting, search, and export across large RNA splicing result sets, with workflow support for scientific review.

Scientific visualizations

Per-result reports with statistical charts, reproducibility views, genome browser context, and links to supporting scientific references. Built so the interface still degrades cleanly when data is incomplete.

Dataset pipeline

Multiple ingestion paths for 100+ TB-class genomic datasets, along with status tracking, notifications, and preparation steps to make those datasets usable inside the product workflow.

Multi-tenant access control

Multi-tenant account architecture with role-based permissions, project-level access controls, and branded environments for different client organizations.

Infrastructure

Dockerized application. Dev, staging, and production environments on Azure. Error tracking, static analysis, deployment automation. Upgraded the full stack (Ruby, Rails, Bootstrap) during the engagement.

What changed for the client

What happened after the platform reached production.

Platform shipped as the company's flagship commercial product

Client closed a $2M+ seed round after launch

Client secured a research collaboration with a major global biotech

Client raised a Series A from tier-1 venture firms

Client grew total funding to $45M+ across multiple rounds

What this shows about the model

The team learned RNA splicing biology well enough to work directly with research scientists, not just take specifications.

SD owned the full build: experiment engine, data visualization, multi-tenant architecture, dataset pipeline, cloud infrastructure.

400+ tickets across 12+ months. Ten engineers shipping against a real product roadmap.

The platform became the commercial product the client used to raise funding and sign pharma partnerships.

The founding team is still in contact eight years later.

A full platform build with embedded engineers

The team learned the domain, built the product, and shipped production software the client still uses commercially. That is how embedded engineering is supposed to work.